T-Cell Biomarker Predicts Response to CAR T-Cell Therapy in Patients With CLL – Medscape
Medscape |
T-Cell Biomarker Predicts Response to CAR T-Cell Therapy in Patients With CLL
Medscape Patients with CLL who had healthier, "early memory" cytotoxic T cells, marked by the expression of CD8 and CD27, as well as the absence of CD45RO, were far more likely to achieve a complete or partial response to treatment. "Our biomarker, which is … |
